Feverfew: Modest Relief for Migraine Frequency and Duration
- MigraineMind
- Dec 22, 2025
- 1 min read
Research Summary
A recent systematic review and meta-analysis published in Natural Product Research evaluated the efficacy of feverfew (Tanacetum parthenium) for migraine relief. Analyzing nine double-masked, placebo-controlled randomized controlled trials with 899 participants, researchers found that feverfew significantly reduced migraine frequency and duration. Specifically, the frequency of migraine attacks decreased by an average of 1.11, and the duration was reduced by 4.43 hours. However, feverfew did not significantly impact pain severity or associated symptoms like nausea and photophobia. Despite moderate heterogeneity and bias risks, feverfew shows modest potential in migraine prevention, highlighting the need for further high-quality research.
Study Details
👥 Research Team: Nelaturi V et al.
📚 Published In: Nat Prod Res
📅 Publication Date: 2025 Dec 21
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.